The Diabetes Ten City Challenge: interim clinical and humanistic outcomes of a multisite community pharmacy diabetes care program

Fera, Toni; Bluml, Benjamin M.; Ellis, William M.; Schaller, Cynthia W.; Garrett, Daniel

doi:10.1331/japha.2008.07166

Cited by 92 publications

(38 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The majority of participants receiving self management interventions from community pharmacists for asthma (89%) and diabetes (97.5%) were also satisfied with the care they received from the pharmacist [54,80]. Only 71% and 61% of those receiving the asthma self management interventions were satisfied by the education and counselling provided by physicians and nurses respectively [54].…”

Section: Resultsmentioning

confidence: 99%

Public health in community pharmacy: A systematic review of pharmacist and consumer views

2011

View full text Add to dashboard Cite

BackgroundThe increasing involvement of pharmacists in public health will require changes in the behaviour of both pharmacists and the general public. A great deal of research has shown that attitudes and beliefs are important determinants of behaviour. This review aims to examine the beliefs and attitudes of pharmacists and consumers towards pharmaceutical public health in order to inform how best to support and improve this service.MethodsFive electronic databases were searched for articles published in English between 2001 and 2010. Titles and abstracts were screened by one researcher according to the inclusion criteria. Papers were included if they assessed pharmacy staff or consumer attitudes towards pharmaceutical public health. Full papers identified for inclusion were assessed by a second researcher and data were extracted by one researcher.ResultsFrom the 5628 papers identified, 63 studies in 67 papers were included. Pharmacy staff: Most pharmacists viewed public health services as important and part of their role but secondary to medicine related roles. Pharmacists' confidence in providing public health services was on the whole average to low. Time was consistently identified as a barrier to providing public health services. Lack of an adequate counselling space, lack of demand and expectation of a negative reaction from customers were also reported by some pharmacists as barriers. A need for further training was identified in relation to a number of public health services. Consumers: Most pharmacy users had never been offered public health services by their pharmacist and did not expect to be offered. Consumers viewed pharmacists as appropriate providers of public health advice but had mixed views on the pharmacists' ability to do this. Satisfaction was found to be high in those that had experienced pharmaceutical public healthConclusionsThere has been little change in customer and pharmacist attitudes since reviews conducted nearly 10 years previously. In order to improve the public health services provided in community pharmacy, training must aim to increase pharmacists' confidence in providing these services. Confident, well trained pharmacists should be able to offer public health service more proactively which is likely to have a positive impact on customer attitudes and health.

show abstract

Section: Resultsmentioning

confidence: 99%

Public health in community pharmacy: A systematic review of pharmacist and consumer views

2011

View full text Add to dashboard Cite

show abstract

“…The interventions were measured for their effectiveness using the following: clinical outcomes, such as glycemic control, 29 , 34 – 43 reduction of risk factors (such as blood pressure, lipids, and body mass index [BMI]), 29 , 35 , 42 – 44 medication adherence, 34 , 38 , 44 – 46 screening for complications, 43 and drug-related problems identified/solved; 35 , 37 , 38 , 42 , 45 humanistic/social outcomes, such as quality of life, 27 , 35 , 36 , 42 , 47 satisfaction, 42 , 46 belief, 45 knowledge, 27 , 37 , 38 , 41 , 42 lifestyle changes, 44 and self-care activity; 47 economic outcomes, such as health costs. 42 , 43 …”

Section: Evidence Of the Benefits Of Pharmacists In The Care Of T2dm mentioning

confidence: 99%

“…clinical outcomes, such as glycemic control, 29 , 34 – 43 reduction of risk factors (such as blood pressure, lipids, and body mass index [BMI]), 29 , 35 , 42 – 44 medication adherence, 34 , 38 , 44 – 46 screening for complications, 43 and drug-related problems identified/solved; 35 , 37 , 38 , 42 , 45…”

Section: Evidence Of the Benefits Of Pharmacists In The Care Of T2dm mentioning

confidence: 99%

The role of the pharmacist in the management of type 2 diabetes: current insights and future directions

Hughes¹,

Wibowo²,

Sunderland³

et al. 2017

IPRP

View full text Add to dashboard Cite

Type 2 diabetes is a chronic disease occurring in ever increasing numbers worldwide. It contributes significantly to the cost of health globally; however, its management remains in the most part less than optimal. Patients must be empowered to self-manage their disease, and they do this in partnership with health care professionals. Whilst the traditional role of the pharmacist has been centered around the supply of medicines and patient counseling, there is an evergrowing body of evidence that pharmacists, through a range of extended services, may contribute positively to the clinical and humanistic outcomes of those with diabetes. Further, these services can be delivered cost-effectively. This paper provides a review of the current evidence supporting the role of pharmacists in diabetes care, whilst providing a commentary of the future roles of pharmacists in this area.

show abstract

“…62,63 Indeed, evidence suggests that for individuals with diabetes and depression, using patient-centered care models to target different levels of barriers to care at the same time can enhance health outcomes and satisfaction. 65–72 The INDEPENDENT integrated care model is therefore a promising strategy to improve access to mental health care and also improve mental health and cardiometabolic outcomes.…”

Section: Discussionmentioning

confidence: 99%

The INtegrating DEPrEssioN and Diabetes treatmENT (INDEPENDENT) study: Design and methods to address mental healthcare gaps in India

Kowalski

Poongothai

Chwastiak

et al. 2017

Contemporary Clinical Trials

View full text Add to dashboard Cite

Introduction Depression and diabetes are highly prevalent worldwide and often co-exist, worsening outcomes for each condition. Barriers to diagnosis and treatment are exacerbated in low and middle-income countries with limited health infrastructure and access to mental health treatment. The INtegrating DEPrEssioN and Diabetes treatmENT (INDEPENDENT) study tests the sustained effectiveness and cost-effectiveness of a multi-component care model for individuals with poorly-controlled diabetes and depression in diabetes clinics in India. Materials and Methods Adults with diabetes, depressive symptoms (Patient Health Questionnaire-9 score ≥10), and ≥1 poorly-controlled cardiometabolic indicator (either HbA1c ≥8.0%, SBP ≥140mmHg, and/or LDL ≥130mg/dl) were enrolled and randomized to the intervention or usual care. The intervention combined collaborative care, decision-support, and population health management. The primary outcome is the between-arm difference in the proportion of participants achieving combined depression response (≥50% reduction in Symptom Checklist score from baseline) AND one or more of: ≥0.5% reduction in HbA1c, ≥5 mmHg reduction in SBP, or ≥10 mg/dl reduction in LDL-c at 24 months (12-month intervention; 12-month observational follow-up). Other outcomes include control of individual parameters, patient-centered measures (i.e. treatment satisfaction), and cost-effectiveness. Results The study trained seven care coordinators. Participant recruitment is complete – 940 adults were screened, with 483 eligible, and 404 randomized (196 to intervention; 208 to usual care). Randomization was balanced across clinic sites. Conclusions The INDEPENDENT model aims to increase access to mental health care and improve depression and cardiometabolic disease outcomes among complex patients with diabetes by leveraging the care provided in diabetes clinics in India (clinicaltrials.gov number: NCT02022111).

show abstract

The Diabetes Ten City Challenge: interim clinical and humanistic outcomes of a multisite community pharmacy diabetes care program

Cited by 92 publications

References 4 publications

Public health in community pharmacy: A systematic review of pharmacist and consumer views

Public health in community pharmacy: A systematic review of pharmacist and consumer views

The role of the pharmacist in the management of type 2 diabetes: current insights and future directions

The INtegrating DEPrEssioN and Diabetes treatmENT (INDEPENDENT) study: Design and methods to address mental healthcare gaps in India

Contact Info

Product

Resources

About